These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 18056833)

  • 61. Treating the full spectrum of dementia with memantine.
    Winblad B; Jelic V
    Int J Geriatr Psychiatry; 2003 Sep; 18(Suppl 1):S41-6. PubMed ID: 12973749
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Magnesium supplementation in the treatment of dementia patients.
    Ozturk S; Cillier AE
    Med Hypotheses; 2006; 67(5):1223-5. PubMed ID: 16790324
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Factors affecting usage patterns of memantine in Alzheimer disease.
    Lerner AJ; McClendon MJ; Sami SA; Ogrocki PK; Adams KB; Smyth KA
    Alzheimer Dis Assoc Disord; 2008; 22(2):137-43. PubMed ID: 18525285
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The use of aromatherapy to treat behavioural problems in dementia.
    Nguyen QA; Paton C
    Int J Geriatr Psychiatry; 2008 Apr; 23(4):337-46. PubMed ID: 17918182
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Measuring therapeutic efficacy in patients with Alzheimer's disease: role of instruments.
    Riepe MW; Janetzky W; Lemming OM
    Dement Geriatr Cogn Disord; 2011; 31(3):233-8. PubMed ID: 21474932
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Stroke, Alzheimer's patients may benefit from AIDS dementia drug.
    Dent Today; 1997 Feb; 16(2):29. PubMed ID: 9560599
    [No Abstract]   [Full Text] [Related]  

  • 67. A double-blind, placebo-controlled trial of memantine in age-associated memory impairment (memantine in AAMI).
    Ferris S; Schneider L; Farmer M; Kay G; Crook T
    Int J Geriatr Psychiatry; 2007 May; 22(5):448-55. PubMed ID: 17117395
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Efficacy of music therapy in the treatment of behavioral and psychiatric symptoms of dementia.
    Raglio A; Bellelli G; Traficante D; Gianotti M; Ubezio MC; Villani D; Trabucchi M
    Alzheimer Dis Assoc Disord; 2008; 22(2):158-62. PubMed ID: 18525288
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Memantine for prophylaxis of chronic tension-type headache--a double-blind, randomized, crossover clinical trial.
    Lindelof K; Bendtsen L
    Cephalalgia; 2009 Mar; 29(3):314-21. PubMed ID: 19220313
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials.
    Rahimi R; Nikfar S; Abdollahi M
    Clin Ther; 2008 May; 30(5):884-901. PubMed ID: 18555935
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Pharmacological treatment of behavioral symptoms in dementia patients].
    Gabryelewicz T
    Przegl Lek; 2014; 71(4):215-20. PubMed ID: 25141581
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Validity and reliability of the newly translated Hellenic Neuropsychiatric Inventory (H-NPI) applied to Greek outpatients with Alzheimer's disease: a study of disturbing behaviors among referrals to a memory clinic.
    Politis AM; Mayer LS; Passa M; Maillis A; Lyketsos CG
    Int J Geriatr Psychiatry; 2004 Mar; 19(3):203-8. PubMed ID: 15027034
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Memantine hydrochloride in the treatment of dementia subtypes.
    Peng D; Yuan X; Zhu R
    J Clin Neurosci; 2013 Nov; 20(11):1482-5. PubMed ID: 24035650
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The effect of pramipexole on mood and motivational symptoms in Parkinson's disease: a meta-analysis of placebo-controlled studies.
    Leentjens AF; Koester J; Fruh B; Shephard DT; Barone P; Houben JJ
    Clin Ther; 2009 Jan; 31(1):89-98. PubMed ID: 19243709
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Validity and reliability of the Japanese Version of the Neuropsychiatric Inventory-Nursing Home Version (NPI-NH)].
    Shigenobu K; Hirono N; Tabushi K; Ikeda M
    Brain Nerve; 2008 Dec; 60(12):1463-9. PubMed ID: 19110758
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of discontinuing cholinesterase inhibitor therapy on behavioral and mood symptoms in nursing home patients with dementia.
    Daiello LA; Ott BR; Lapane KL; Reinert SE; Machan JT; Dore DD
    Am J Geriatr Pharmacother; 2009 Apr; 7(2):74-83. PubMed ID: 19447360
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The effect of 12-week open-label memantine treatment on cognitive function improvement in patients with alcohol-related dementia.
    Cheon Y; Park J; Joe KH; Kim DJ
    Int J Neuropsychopharmacol; 2008 Nov; 11(7):971-83. PubMed ID: 18346293
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The effect of memantine on sleep architecture and psychiatric symptoms in patients with Alzheimer's disease.
    Ishikawa I; Shinno H; Ando N; Mori T; Nakamura Y
    Acta Neuropsychiatr; 2016 Jun; 28(3):157-64. PubMed ID: 26572055
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Impact of Donepezil and Memantine on Behavioral and Psychological Symptoms of Alzheimer Disease: Six-month Open-label Study.
    Bago Rožanković P; Rožanković M; Badžak J; Stojić M; Šušak Sporiš I
    Cogn Behav Neurol; 2021 Dec; 34(4):288-294. PubMed ID: 34851866
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [The challenge of Alzheimer dementia].
    Pharm Unserer Zeit; 2003; 32(1):77. PubMed ID: 12577765
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.